GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ME Therapeutics Holding Inc (XCNQ:METX) » Definitions » Short-Term Debt

ME Therapeutics Holding (XCNQ:METX) Short-Term Debt : C$0.00 Mil (As of Feb. 2024)


View and export this data going back to 2023. Start your Free Trial

What is ME Therapeutics Holding Short-Term Debt?

ME Therapeutics Holding's Short-Term Debt for the quarter that ended in Feb. 2024 was C$0.00 Mil.

ME Therapeutics Holding's quarterly Short-Term Debt stayed the same from Aug. 2023 (C$0.04 Mil) to Nov. 2023 (C$0.04 Mil) but then declined from Nov. 2023 (C$0.04 Mil) to Feb. 2024 (C$0.00 Mil).

ME Therapeutics Holding's annual Short-Term Debt increased from . 20 (C$0.00 Mil) to Aug. 2022 (C$0.13 Mil) but then declined from Aug. 2022 (C$0.13 Mil) to Aug. 2023 (C$0.04 Mil).


ME Therapeutics Holding Short-Term Debt Historical Data

The historical data trend for ME Therapeutics Holding's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ME Therapeutics Holding Short-Term Debt Chart

ME Therapeutics Holding Annual Data
Trend Aug22 Aug23
Short-Term Debt
0.13 0.04

ME Therapeutics Holding Quarterly Data
Aug22 Dec22 May23 Aug23 Nov23 Feb24
Short-Term Debt Get a 7-Day Free Trial 0.06 0.04 0.04 0.04 -

ME Therapeutics Holding Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


ME Therapeutics Holding Short-Term Debt Related Terms

Thank you for viewing the detailed overview of ME Therapeutics Holding's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


ME Therapeutics Holding (XCNQ:METX) Business Description

Comparable Companies
Traded in Other Exchanges
Address
177 Robson Street, Vancouver, BC, CAN, V6B 0N3
ME Therapeutics Holding Inc operates its business through ME Therapeutics. It is a preclinical-stage biotechnology company working on novel cancer-fighting drugs in the field of Immuno-Oncology (IO). It is developing preclinical data for its myeloid-targeted candidate assets using validated cancer models.

ME Therapeutics Holding (XCNQ:METX) Headlines

No Headlines